Peter W. Collins

22.9k total citations · 2 hit papers
252 papers, 11.9k citations indexed

About

Peter W. Collins is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Peter W. Collins has authored 252 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Hematology, 60 papers in Genetics and 35 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Peter W. Collins's work include Hemophilia Treatment and Research (118 papers), Platelet Disorders and Treatments (91 papers) and Blood Coagulation and Thrombosis Mechanisms (61 papers). Peter W. Collins is often cited by papers focused on Hemophilia Treatment and Research (118 papers), Platelet Disorders and Treatments (91 papers) and Blood Coagulation and Thrombosis Mechanisms (61 papers). Peter W. Collins collaborates with scholars based in United Kingdom, United States and Netherlands. Peter W. Collins's co-authors include Ri Liesner, Rachel Collis, C. R. M. Hay, F. Baudo, Elizabeth Chalmers, Angela Huth‐Kühne, Paul Knoebl, David Keeling, Michael D. Williams and H. Lévesque and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Peter W. Collins

246 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study

2017 309 citations Peter W. Collins et al. profile →
International recommendations on the diagnosis and treatment of acquired hemophilia A

2020 183 citations Peter W. Collins, Paul Knoebl et al. profile →

Peers

Countries citing papers authored by Peter W. Collins

Since Specialization

Citations

This map shows the geographic impact of Peter W. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Collins more than expected).

Fields of papers citing papers by Peter W. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Collins. The network helps show where Peter W. Collins may publish in the future.

Co-authorship network of co-authors of Peter W. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Collins. A scholar is included among the top collaborators of Peter W. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Collins. Peter W. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating membrane aminophospholipids contribute to thrombotic risk in rheumatoid arthritis 2025 ·Journal of Lipid Research ·(unknown), Majd Protty, Victoria J. Tyrrell, (unknown), (unknown), Ben Mead, Martin Giera, Peter W. Collins, P. Vincent Jenkins, Ernest Choy, Simon A. Jones, Valerie B. O’Donnell	0
2	Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V 2025 ·Blood Advances ·Peter W. Collins, Claire S. Whyte, L. de Lloyd, (unknown), Sarah Bell, Nicholas Gill, Rachel Collis, P. Vincent Jenkins, Nicola J. Mutch	0
3	Aspirin modulates generation of procoagulant phospholipids in cardiovascular disease, by regulating LPCAT3 2024 ·Journal of Lipid Research ·Majd Protty, Victoria J. Tyrrell, (unknown), (unknown), (unknown), Yong Li, (unknown), (unknown), David C. Bosanquet, Alex Reed, (unknown), (unknown), Hideo Shindou, Benjamin F. Cravatt, Alastair W. Poole, Takao Shimizu, Zaheer Yousef, Peter W. Collins, Valerie B. O’Donnell	3
4	The OBS UK Dashboard: an interactive tool for representative trial site selection to facilitate equality and diversity in maternity research 2024 ·Trials ·(unknown), Tanvi Rai, Philip Pallmann, Julia Townson, Sarah J. Kotecha, Mairead Black, Julia Sanders, Rachel Collis, Peter W. Collins, (unknown), Pensée Wu, Sarah Bell, William Parry‐Smith	1
5	A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B 2023 ·British Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), Frank W.G. Leebeek, Karin Fijnvandraat, Michiel Coppens, Mary Mathias, Peter W. Collins, Robert C. Tait, Catherine Bagot, Nicola Curry, Jeanette Payne, Pratima Chowdary, Marjon H. Cnossen, Ron A. A. Mathôt	3
6	Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study 2023 ·Journal of Thrombosis and Haemostasis ·L. de Lloyd, P. Vincent Jenkins, Sarah Bell, Nicola J. Mutch, (unknown), (unknown), Donna James, (unknown), (unknown), (unknown), (unknown), Rachel Collis, Peter W. Collins	26
7	Phosphatidylthreonine is a procoagulant lipid detected in human blood and elevated in coronary artery disease 2023 ·Journal of Lipid Research ·(unknown), Majd Protty, (unknown), (unknown), Nader Omidvar, (unknown), Yugo Iwasaki, (unknown), P. Vincent Jenkins, Zaheer Yousef, (unknown), (unknown), (unknown), (unknown), Parveen Yaqoob, James H. Morrissey, Peter W. Collins, Valerie B. O’Donnell	1
8	The role of procoagulant phospholipids on the surface of circulating blood cells in thrombosis and haemostasis 2022 ·Open Biology ·Majd Protty, Patrick Jenkins, Peter W. Collins, Valerie B. O’Donnell	19
9	Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study 2021 ·Blood Advances ·Paul van der Valk, Michael Makris, Kathelijn Fischer, Robert C. Tait, Pratima Chowdary, Peter W. Collins, Karina Meijer, Lize F. D. van Vulpen, Eveline P. Mauser‐Bunschoten, Roger E. G. Schutgens	18
10	Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update 2021 ·Haemophilia ·Daniel P. Hart, Jayanthi Alamelu, Neha Bhatnagar, Tina Biss, Peter W. Collins, Georgina Hall, C. R. M. Hay, Ri Liesner, Michael Makris, Mary Mathias, Jayashree Motwani, Ben Palmer, Jeanette Payne, Charles Percy, Michael Richards, Anne Riddell, Kate Talks, Oliver Tunstall, Elizabeth Chalmers	17
11	A WITHIN-PATIENT COMPARISON OF EFFICACY AND OUTCOME OF RECOMBINANT FIX AND FIXFC IN HAEMOPHILIA B IN THE UK 2020 ·Haemophilia ·(unknown), M.J. Scott, C. R. M. Hay, Peter W. Collins, Hua Xiang, Susan Shapiro, Pratima Chowdary, Emily Symington, Richard Gooding, (unknown)	2
12	Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011 2014 ·Blood ·Peter W. Collins, (unknown), Elizabeth Chalmers, Daniel P. Hart, Ri Liesner, Savita Rangarajan, (unknown), Michael D. Williams, C. R. M. Hay	81
13	Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study 2014 ·Blood ·Peter W. Collins, (unknown), D. Bruynseels, (unknown), Rebecca Cannings‐John, E. Precious, Vincent Hamlyn, Julia Sanders, Raza Alikhan, Rachel Rayment, Alexandra Rees, (unknown), Judith E. Hall, Shantini Paranjothy, Andrew Weeks, Rachel Collis	159
14	Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects 2013 ·Blood ·Jacqueline Stockley, Neil V. Morgan, Danai Bem, Gillian Lowe, Marie Lordkipanidzé, Ban B. Dawood, Michael A. Simpson, (unknown), (unknown), Vincenzo Leo, (unknown), Jayashree Motwani, Jonathan T. Wilde, Peter W. Collins, Michael Makris, Steve P. Watson, Martina E. Daly	79
15	Cardiovascular disease history and risk factors in hemophilia patients 2012 ·Haemophilia ·(unknown), Kathelijn Fischer, Michael Makris, Christopher Tait, Pratima Chowdary, Peter W. Collins, Karina Meijer, G. Roosendaal, Roger E. G. Schutgens, (unknown)	1
16	Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 2012 ·Journal of Thrombosis and Haemostasis ·Paul Knoebl, Pascual Marco, F. Baudo, Peter W. Collins, Angela Huth‐Kühne, László Nemes, Fabio Pellegrini, Lilian Tengborn, H. Lévesque	326
17	Communicating about haemophilia within the family: the importance of context and of experience 2007 ·Haemophilia ·(unknown), Paula Boddington, Rebecca Dimond, Paul Atkinson, Angus Clarke, Peter W. Collins	27
18	Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients 2004 ·British Journal of Haematology ·(unknown), A Saayman, U. Paulus, George Findlay, Peter W. Collins	282
19	A new polymorphism in the human factor VIII gene: implications for linkage analysis in haemophilia A and for the evolution of int22h sequences 2000 ·British Journal of Haematology ·D. J. Bowen, Carlos Daniel De Brasi, Irene Larripa, Peter W. Collins	7
20	Keratinocyte Alterations in Skin Tumour Development 1993 ·Recent results in cancer research ·I. M. Leigh, Patricia E. Purkis, Andrew C. Markey, Peter W. Collins, S. Neill, (unknown), Mary Glover, E. Birgitte Lane	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact